Oxazolidin-2-one and thiazolidin-2-one derivatives for use as EP4 receptor agonists in the treatment of glaucoma
A Standard patent application filed on 25 August 2003 credited to Colucci, John ; Wilson, Marie-Claire ; Han, Yongxin ; Billot, Xavier ; Young, Robert

Details

Application number :
2003258433  
Application type :
Standard  
Application status :
LAPSED  
Under opposition :
No  
Proceeding type :
 
Invention title :
Oxazolidin-2-one and thiazolidin-2-one derivatives for use as EP4 receptor agonists in the treatment of glaucoma  
Inventor :
Colucci, John ; Wilson, Marie-Claire ; Han, Yongxin ; Billot, Xavier ; Young, Robert  
Agent name :
Spruson & Ferguson  
Address for service :
Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 Australia  
Filing date :
25 August 2003  
Associated companies :
 
Applicant name :
Merck Frosst Canada Ltd  
Applicant address :
16711 Trans-Canada Highway Kirkland Quebec H9H 3L1 Canada  
Old name :
Merck Frosst Canada & Co.  
Original Source :
Go  

Same Inventor